Mounjaro Price Hike: UK Users Devastated

Here’s a breakdown of the key points from the provided text, focusing on the issues surrounding Mounjaro and Wegovy:

shortages & Self-Dosing: Some patients are ⁣facing shortages of Mounjaro and are resorting to risky practices like ordering higher-strength doses and attempting to calculate their own dosage ‍by counting clicks on the pen injector. This is driven by fear of losing access to the medication.
Life-Changing Results: Mounjaro is⁤ described as considerably improving the lives of patients like Polly, a retired NHS worker. ⁣She’s experienced substantial weight loss (almost 25kg) and improved breathing due to COPD.
Price Increases & Switching Medications: The rising cost of Mounjaro is forcing patients to consider ‍alternatives. Polly plans to switch to Wegovy, a cheaper option, despite concerns about its potential ⁢effectiveness.
Reluctance to Switch: Many patients are hesitant⁣ to switch from Mounjaro to Wegovy, fearing new side effects or a less effective weight loss experience. Studies suggest Wegovy may be less effective for weight loss than Mounjaro.
* Financial Strain: The cost of these medications is creating a financial burden ⁢for patients,even with reduced food costs due⁣ to appetite suppression.

In essence,⁣ the article highlights a growing problem: a beneficial medication⁣ (Mounjaro) is becoming less accessible due to shortages and price ⁣increases, forcing patients to make difficult choices ⁤about their health and potentially resort to unsafe practices or ⁢less⁢ effective alternatives.